-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, the official website of CDE showed that Shijiazhuang's four-drug argatroban injection was accepted as a generic 4 type of argatroban injection
According to data, argatroban was developed by Mitsubishi Tanabe of Japan.
Sales of terminal argatroban injection in public medical institutions in China in recent years (unit: 100 million yuan)
Source: Terminal competition landscape of China's public medical institutions
According to data from Menet.
There are 7 manufacturers of argatroban injection including Tianjin Pharmaceutical Research Institute Pharmaceutical, Shandong New Times Pharmaceutical, Nanjing Zhengda Tianqing Pharmaceutical, etc.
It is worth mentioning that 15 companies for Argatroban injection have submitted listing applications for review and approval.
Source: CDE official website, Minet database